Kimberly Dias 38th Lorne Cancer Conference 2026

Abstracts this author is presenting:

• Deciphering Mitotic and DNA Damage Pathways Driving Malignant Rhabdoid Tumour: Preclinical and Mechanistic Evaluation of Alisertib, Temozolomide, and Irinotecan Combination Therapy — Welcome Reception & Poster Session 1